Cyclophosphamide is a generic injectable solution and capsule prescribed to treat conditions such as certain cancers and nephrotic syndrome. The cost of cyclophosphamide, with and without insurance, ...

Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...

Efficacy of neoadjuvant immunotherapy in head and neck squamous carcinoma (HNSCC): A systematic review and meta-analysis. Utilizing the EORTC Item Library to develop a tailored patient-reported ...

Nexus Pharmaceuticals shared that on May 9, 2025, it won a patent litigation involving injectable cyclophosphamide, a drug that has been approved for certain kinds of cancer. Nexus had been pursuing a ...

More than one-quarter of the patients with AAV in the unmatched sample were initially treated with cyclophosphamide, making the findings clinically relevant. Patients with antineutrophil cytoplasmic ...